Related Experiment Videos
Antiretroviral therapy: factors associated with adherence
1Yale School of Nursing, New Haven, CT, USA.
The Journal of the Association of Nurses in AIDS Care : JANAC
|January 1, 1997
Summary
Patient adherence to highly active antiretroviral therapies is crucial for clinical effectiveness. Nonadherence leads to suboptimal drug levels, increasing the risk of antiretroviral resistance, highlighting the need for consistent adherence definitions and measurement strategies.
Area of Science:
- Pharmacology
- Public Health
- Behavioral Science
Background:
- Clinical effectiveness of highly active antiretroviral therapies (HAART) is significantly influenced by patient adherence to complex medication schedules.
- Nonadherence can result in suboptimal drug concentrations, which are strongly linked to the emergence of antiretroviral resistance.
Purpose of the Study:
- To highlight the critical role of patient adherence in the success of highly active antiretroviral therapies.
- To underscore the challenges in defining and measuring adherence due to its complex nature.
- To identify key factors influencing adherence to medical regimens.
Main Methods:
- Literature review and conceptual analysis of adherence in the context of antiretroviral therapy.
- Examination of the relationship between adherence, drug levels, and resistance development.
- Exploration of the multifaceted nature of adherence as a dynamic behavioral process.
Main Results:
- Inconsistent definitions and measurement difficulties complicate the assessment of patient adherence.
- Adherence is a dynamic process influenced by regimen, provider, patient, and societal factors.
- Suboptimal adherence is a significant driver for the development of antiretroviral resistance.
Conclusions:
- Accurate measurement and consistent definitions of adherence are essential for evaluating HAART effectiveness.
- Understanding the dynamic interplay of factors influencing adherence is critical for developing effective interventions.
- Improving adherence is paramount to preventing antiretroviral resistance and optimizing patient outcomes.